Skip to main navigation Skip to search Skip to main content

Intestinal and enthesis innate immunity in early axial spondyloarthropathy

  • Kassem Sharif*
  • , Charlie Bridgewood
  • , Sayam Dubash
  • , Dennis McGonagle
  • *Corresponding author for this work
  • University of Leeds
  • University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

Axial SpA (axSpA), encompassing AS, is a multifactorial disease that localizes to sites of high spinal biomechanical stress. Much has been written on T cells and adaptive immunity in axSpA, which is understandable given the very strong HLA-B27 disease association. Extra-axial disease characteristically involves the anterior uveal tract, aortic root, lung apex and terminal ileum. Under recent classification, axSpA is classified as an intermediate between autoimmunity and autoinflammatory disease, with the latter term being synonymous with innate immune dysregulation. The purpose of this review is to evaluate the 'danger signals' from both the exogenous intestinal microbiotal adjuvants or pathogen-associated molecular patterns that access the circulation and endogenously derived damaged self-tissue or damage-associated molecular patterns derived from entheses and other sites of high biomechanical stress or damage that may serve as key drivers of axSpA onset, evolution, disease flares and eventual outcomes.

Original languageEnglish
Pages (from-to)IV67-IV78
JournalBritish Journal of Rheumatology
Volume59
DOIs
StatePublished - 1 Oct 2020

Keywords

  • axial spondyloarthritis (axSpA)
  • damage-associated molecular patterns (DAMPs)
  • danger signals
  • enthesitis
  • pathogen-associated molecular patterns (PAMPs)

Fingerprint

Dive into the research topics of 'Intestinal and enthesis innate immunity in early axial spondyloarthropathy'. Together they form a unique fingerprint.

Cite this